Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional Results available

A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)

ClinicalTrials.gov ID: NCT04710576

Public ClinicalTrials.gov record NCT04710576. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 11:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

AGAVE-201, A Phase 2, Open-label, Randomized, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of Axatilimab at 3 Different Doses in Patients With Recurrent or Refractory Active Chronic Graft Versus Host Disease Who Have Received at Least 2 Lines of Systemic Therapy

Study identification

NCT ID
NCT04710576
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Syndax Pharmaceuticals
Industry
Enrollment
241 participants

Conditions and interventions

Interventions

  • Axatilimab Drug

Drug

Eligibility (public fields only)

Age range
2 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 3, 2021
Primary completion
Apr 6, 2023
Completion
Aug 31, 2027
Last update posted
Mar 15, 2026

2021 – 2027

United States locations

U.S. sites
47
U.S. states
26
U.S. cities
40
Facility City State ZIP Site status
University of Alabama at Birmingham - Children's of Alabama Birmingham Alabama 35233
University of Alabama at Birmingham Birmingham Alabama 35294
City of Hope Duarte California 91010
University of Southern California Norris Comprehensive Cancer Center Los Angeles California 90033
University of California, Los Angeles (UCLA) - Medical Center Los Angeles California 90059
Stanford Cancer Center Stanford California 94305
Children's National Medical Center Washington D.C. District of Columbia 20010
University of Florida (UF) Gainesville Florida 32610
Mayo Clinic - Jacksonville Jacksonville Florida 32224
University of Miami Miami Florida 33136
AdventHealth Orlando Orlando Florida 32806
Moffitt Tampa Florida 33612
Emory University Atlanta Georgia 30322
Northside Hospital Atlanta Georgia 30342
The University of Chicago Medical Center (UCMC) Chicago Illinois 60637
Indiana University Health Melvin and Bren Simon Cancer Center Indianapolis Indiana 46202
Franciscan Health Indianapolis Indianapolis Indiana 46237
Tulane University Medical Center New Orleans Louisiana 70112
Johns Hopkins Kimmel Cancer Center Baltimore Maryland 21231-2410
Massachusetts General Hospital Boston Massachusetts 02114
Dana Farber Cancer Institute Boston Massachusetts 02215
University of Massachusetts Memorial Medical Center Worcester Massachusetts 01655
University of Michigan Ann Arbor Michigan 48084
Barbara Ann Karmanos Cancer Institute Detroit Michigan 48201
Henry Ford Hospital Detroit Michigan 48202
University of Minnesota Minneapolis Minnesota 55455
Mayo Clinic - Rochester Rochester Minnesota 55905
Washington University School of Medicine St Louis Missouri 63110
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08903
Weill Medical College of Cornell University New York New York 10022
Stony Brook University Medical Center Stony Brook New York 11794
Wake Forest Winston-Salem North Carolina 27157
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229
University Hospitals Cleveland Medical Center Cleveland Ohio 44106
The Ohio State University Comprehensive Cancer Center Columbus Ohio 43210
The Cleveland Clinic Foundation Lyndhurst Ohio 44195
University of Oklahoma - Health Sciences Center Oklahoma City Oklahoma 73104
Oregon Health & Science University Portland Oregon 97239
University of Pittsburgh Medical Center - Hillman Cancer Center Pittsburgh Pennsylvania 15232
Vanderbilt University Medical Center Nashville Tennessee 37232
MD Anderson Cancer Center Houston Texas 77030
Intermountain Healthcare Salt Lake City Utah 84111
University of Utah Salt Lake City Utah 84112
University of Virginia Medical Center Charlottesville Virginia 22908
Fred Hutchinson Cancer Research Center Seattle Washington 98109
University of Wisconsin - Carbone Cancer Center Madison Wisconsin 53792
Froedtert Hospital and the Medical College of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 74 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04710576, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 15, 2026 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04710576 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →